HOME
ABOUT
OUR STORY
PATIENT ADVOCACY
TEAM
SCIENTIFIC ADVISORY BOARD
OUR SCIENCE
THERAPEUTIC APPROACH
GPCRs AND CLPP IN ONCOLOGY
IMIPRIDONES
PUBLICATIONS
DEVELOPMENT
PIPELINE
ONC201
ONC206
ONC212
IMIPRIDONE PLATFORM
ONC201
FOR PATIENTS
FOR PHYSICIANS
EXPANDED ACCESS
EXPANDED ACCESS FAQS
NEURO-ONCOLOGY
NEWS
PRESS RELEASES
IN THE NEWS
EVENTS
CONTACT
CAREERS
HOME
ABOUT
– OUR STORY
– PATIENT ADVOCACY
– TEAM
– SCIENTIFIC ADVISORY BOARD
OUR SCIENCE
– THERAPEUTIC APPROACH
– GPCRs AND CLPP IN ONCOLOGY
– IMIPRIDONES
– PUBLICATIONS
DEVELOPMENT
– PIPELINE
– ONC201
– ONC206
– ONC212
– IMIPRIDONE PLATFORM
ONC201
– FOR PATIENTS
– FOR PHYSICIANS
– EXPANDED ACCESS
– EXPANDED ACCESS FAQS
– NEURO-ONCOLOGY
NEWS
– PRESS RELEASES
– IN THE NEWS
– EVENTS
CONTACT
CAREERS
Oncoceutics will present at the 2020 Glioblastoma Drug Development Summit
Please find more information
here
.
Photostream
Business Development